The Patanjali advertisement case has more than ... it was the “first evidence-based medicine for Covid-19” and the ad poster read the product was certified and recognised by the World Health ...

Haridwar-based Ayurvedic conglomerate, Patanjali has reported robust financial results for the third quarter of the financial year 2024-25 (Q3 FY25). The company’s revenue from operations stood ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

PAT for Nine Months FY 25: INR 942.81 crore, 58.71% year-on-year growth. Patanjali Foods Ltd (BOM:500368) reported the highest ever quarterly revenue from operations at INR 9,103.13 crore ...

Patanjali Foods Ltd on Monday posted a 71.29 per cent jump in standalone net profit to ₹370.93 crore for the December quarter on higher sales. The company had logged a net profit of ₹216.54 ...